Alec van Gelder: From Crisis Care to Continuous Care in SCD
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared a post on LinkedIn:
“This World Sickle Cell Day, Friday 19th June, Novo Nordisk is honored to be part of the global conversation around sickle cell disease (SCD).
Join us on June 19th, 2026 at 11am EST for a Virtual 24-Hour Sickle Cell Awareness and Action Event, in collaboration with the Global Alliance of Sickle Cell Disease Organizations, Alliance of Sickle Cell Disease Organisations (GASCDO), focused on: ‘Closing the Survival Gap in Sickle Cell Disease: From Crisis Care to Chronic, Continuous Care’.
Dr. Ify Osunkwo, Director of Patient Advocacy – Hemoglobinopathies, will be moderating this incredible panel alongside our partners and distinguished global experts. This event is a testament to our commitment to patients living with sickle cell disease worldwide.
Register here: (Dr. Osunkwo’s session begins at 11am EST / 5pm CEST)
Let’s stand together, raise awareness, and drive meaningful change for the sickle cell community!”
Stay updated with Hemostasis Today.
-
Jun 18, 2026, 14:33Zahabia Adnan: Meta-Analysis Supports Rivaroxaban as an Effective Option for Cancer-Associated VTE
-
Jun 18, 2026, 14:17Charlotte Aubin: A New Perspective on BDNF’s Influence on Hemostasis and Thrombotic Risk
-
Jun 18, 2026, 14:01Heghine Khachatryan: Improving Long-Term Outcomes in PE Through Mechanical Thrombectomy
-
Jun 18, 2026, 13:55Shumaila Ishad: Acute Coronary Syndrome – When Every Minute Matters
-
Jun 18, 2026, 13:45Ed Shovelin: Looking Forward to ISTH in Paris
-
Jun 18, 2026, 13:00Armghan Ans: How to Implement the 2026 Extended-Window Stroke IVT Guideline
-
Jun 18, 2026, 12:49Cyndi Serrano: A Welcome Milestone in the Fight Against Underdiagnosed Iron Deficiency
-
Jun 18, 2026, 12:43Marek Trojanowicz: New Real-World Evidence Strengthens the Case for BrainScan in Acute Stroke Care
-
Jun 18, 2026, 12:34Mahsa Asadi Anar: The Next Challenge for AI in Stroke Imaging